BioMed Research International

Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets


Status
Published

Lead Editor

1ICB-UFMG, Belo Horizonte, Brazil

2University of Freiburg Medical School, Freiburg im Breisgau, Germany

3UCSF, San Francisco, USA

4University of Florida, Gainesville, USA

5Asklepios-Med, Szeged, Hungary


Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets

Description

Neuroinflammatory and neurodegenerative disorders affect millions of people worldwide, but the pathophysiological aspects of most of them remain poorly understood. Several molecules have been suggested as participants in the process of these diseases and might represent pharmacological targets.

We invite researchers to submit reviews and original articles that explore the most recent discoveries in the pathological mechanisms of neuroinflammatory and neurodegenerative diseases and potential upcoming therapies.

Potential topics include, but are not limited to:

  • Role of the peripheral immune system in neurodegeneration
  • Role of inflammatory mediators in neurodegeneration
  • Potential targets that control neuroinflammation and degeneration
  • Drugs that reveal neuroprotective and antineuroinflammatory properties
  • From basic to clinical science in neuroimmunopharmacology

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 487241
  • - Editorial

Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets

Antonio Carlos Pinheiro de Oliveira | Eduardo Candelario-Jalil | ... | Helton José dos Reis
  • Special Issue
  • - Volume 2015
  • - Article ID 569123
  • - Research Article

Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis

Guillaume Bonnier | Alexis Roche | ... | Cristina Granziera
  • Special Issue
  • - Volume 2015
  • - Article ID 628192
  • - Review Article

Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies

Natália Pessoa Rocha | Aline Silva de Miranda | Antônio Lúcio Teixeira
  • Special Issue
  • - Volume 2015
  • - Article ID 198612
  • - Review Article

An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington’s Disease

Caroline Zocatelli de Paula | Bruno Daniel Correia Gonçalves | Luciene Bruno Vieira
  • Special Issue
  • - Volume 2015
  • - Article ID 750752
  • - Research Article

Cocaine Causes Apoptotic Death in Rat Mesencephalon and Striatum Primary Cultures

Lucilia B. Lepsch | Cleopatra S. Planeta | Critoforo Scavone
  • Special Issue
  • - Volume 2015
  • - Article ID 189638
  • - Research Article

CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis

Svetlana F. Khaiboullina | Aigul R. Gumerova | ... | Albert A. Rizvanov
  • Special Issue
  • - Volume 2015
  • - Article ID 508342
  • - Research Article

S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer’s Disease

Carla Cirillo | Elena Capoccia | ... | Giuseppe Esposito
  • Special Issue
  • - Volume 2015
  • - Article ID 217961
  • - Research Article

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis

Paulo Diniz da Gama | Luís dos Ramos Machado | ... | Dagoberto Callegaro
  • Special Issue
  • - Volume 2015
  • - Article ID 185891
  • - Research Article

Intellectual Impairment in Patients with Newly Diagnosed HIV Infection in Southwestern Nigeria

Taofiki A. Sunmonu | Johann Sellner | ... | Benedicta Y. Oladimeji
  • Special Issue
  • - Volume 2015
  • - Article ID 716920
  • - Research Article

Peripheral Administration of Tumor Necrosis Factor-Alpha Induces Neuroinflammation and Sickness but Not Depressive-Like Behavior in Mice

Steven Biesmans | Jan A. Bouwknecht | ... | Rony Nuydens
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.